1. Sanchez AP, Ward DM: Therapeutic apheresis for renal disorders.
Semin Dial 2012; 25: 119-131
2. Pusey CD, Levy JB: Plasmapheresis in immunologic renal disease.
Blood Purif 2012; 33: 190-198
3. Dittrich E, Schmaldienst S, Derfler K: Plasma exchange and
immunoadsorption. Wien Klin Wochenschr 2007; 119: 39-53
4. Fukatsu A, Tanaka Y, Iehara N: Double filtration plasmapheresis for
therapy of hyperlipidemia. Nihon Rinsho 2004; 62: 595-598
5. Hershko AY, Naparstek Y: Removal of pathogenic autoantibodies
by immunoadsorption. Ann N Y Acad Sci 2005; 1051: 635-646
6. Ichimaru N, Takahara S: Japan’s experience with living-donor
kidney transplantation across ABO barriers. Nat Clin Pract Nephrol
2008; 4: 682-692
7. Shin M, Kim SJ: ABO Incompatible kidney transplantation-current
status and uncertainties. J Transplant 2011; 2011: 970421
8. Flint SM, Walker RG, Hogan C, Haeusler MN, Robertson A, Francis
DM, Millar R, Finlay M, Landgren A, Cohney SJ: Successful ABOincompatible
kidney transplantation with antibody removal and
standard immunosuppression. Am J Transplant 2011; 11: 1016-1024
9. Higgins R, Lowe D, Hathaway M, Lam FT, Kashi H, Tan LC, Imray
C, Fletcher S, Chen K, Krishnan N, Hamer R, Zehnder D, Briggs D:
Double filtration plasmapheresis in antibody-incompatible kidney
transplantation. Ther Apher Dial 2010 ; 14: 392-399
10. Biglarnia AR, Nilsson B, Nilsson Ekdahl K, Tufveson G, Nilsson
T, Larsson E, Wadström J: Desensitization with antigen-specific
immunoadsorption interferes with complement in ABO-incompatible
kidney transplantation. Transplantation 2012; 93: 87-92
11. Tobian AA, Shirey RS, Montgomery RA, Ness PM, King KE:
The critical role of plasmapheresis in ABO-incompatible renal
transplantation. Transfusion 2008; 48: 2453-2460
12. Tobian AA, Shirey RS, Montgomery RA, Tisch DJ, Ness PM,
King KE: Therapeutic plasma exchange reduces ABO titers to
permit ABO-incompatible renal transplantation. Transfusion 2010;
49:1248-1254
13. Sonnenday CJ, Warren DS, Cooper M, Samaniego M, Haas M, King
KE, Shirey RS, Simpkins CE, Montgomery RA: Plasmapheresis,
CMV hyperimmune globulin, and anti-CD20 allow ABO incompatible renal transplantation without splenectomy. Am J
Transplant 2004; 4: 1315-1322
14. Tydén G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman
I: ABO incompatible kidney transplantations without splenectomy,
using antigen-specific immunoadsorption and rituximab. Am J
Transplant 2005; 5: 145-148
15. Kumlien G, Ullström L, Losvall A, Persson LG, Tydén G: Clinical
experience with a new apheresis filter that specifically depletes
ABO blood group antibodies. Transfusion 2006; 46: 1568-1575
16. Beimler JH, Morath C, Schmidt J, Ovens J, Opelz G, Rahmel A,
Zeier M, Süsal C: Successful deceased-donor kidney transplantation
in crossmatch-positive patients with peritransplant plasma exchange
and Rituximab. Transplantation 2009; 87: 668-671
17. Higgins RM, Bevan DJ, Vaughan RW, Phillips AO, Snowden S,
Bewick M, Scoble JE, Hendry BM: 5-year follow-up of patients
successfully transplanted after immunoadsorption to remove anti-
HLA antibodies. Nephron 1996; 74:53-57
18. Haas M, Böhmig GA, Leko-Mohr Z, Exner M, Regele H, Derfler K,
Hörl WH, Druml W: Peri-operative immunoadsorption in sensitized
renal transplant recipients. Nephrol Dial Transplant 2002 ;17:
1503-1508
19. Lorenz M, Regele H, Schillinger M, Kletzmayr J, Haidbauer B,
Derfler K, Druml W, Böhmig GA: Peritransplant immunoadsorption:
A strategy enabling transplantation in highly sensitized crossmatchpositive
cadaveric kidney allograft recipients. Transplantation 2005;
79: 696-701
20. Wang W, Lıu H, Yın H, Lı XB, Yang XY, Ren L, Hu XP, Wang Y,
Zhang XD: Immunoadsorption in highly sensitized renal transplant
recipients. Zhonghua Yi Xue Za Zhi 2010; 90: 2532-2535
21. Yin H, Hu XP, Li XB, Liu H, Wang W, Ren L, Wang Y, Zhang XD:
Protein A immunoadsorption combined with rituximab in highly
sensitized kidney transplant recipients. Chin Med J (Engl) 2009;
122: 2752-2756
22. Archdeacon P, Chan M, Neuland C, Velidedeoglu E, Meyer J, Tracy
L, Cavaille-Coll M, Bala S, Hernandez A, Albrecht R: Summary of
FDA antibody-mediated rejection workshop. Am J Transplant 2011;
11: 896-906
23. Böhmig GA, Regele H, Exner M, Derhartunian V, Kletzmayr J,
Säemann MD, Hörl WH, Druml W, Watschinger B: C4d-positive
acute humoral renal allograft rejection: Effective treatment by
immunoadsorption. J Am Soc Nephrol 2001; 12: 2482-2489
24. Böhmig GA, Wahrmann M, Regele H, Exner M, Robl B, Derfler K,
Soliman T, Bauer P, Müllner M, Druml W: Immunoadsorption in
severe C4d-positive acute kidney allograft rejection: A randomized
controlled trial. Am J Transplant 2007;7:117-121
25. Gomes AM, Pedroso S, Martins LS, Malheiro J, Viscayno JR, Santos
J, Dias L, Henriques AC, Sarmento AM, Cabrita A: Diagnosis and
treatment of acute humoral kidney allograft rejection.Transplant Proc 2009; 41: 855-858
26. Gungor O, Sen S, Kircelli F, Yilmaz M, Sarsik B, Ozkahya M,
Hoscoskun C, Ok E, Toz H: Plasmapheresis therapy in renal
transplant patients: Five-year experience. Transplant Proc 2011; 43:
853-857
27. Ibernón M, Gil-Vernet S, Carrera M, Serón D, Moreso F, Bestard
O, Cruzado JM, Grinyó JM: Therapy with plasmapheresis and
intravenous immunoglobulin for acute humoral rejection in kidney
transplantation. Transplant Proc 2005; 37: 3743-3745
28. Rocha PN, Butterly DW, Greenberg A, Reddan DN, Tuttle-Newhall
J, Collins BH, Kuo PC, Reinsmoen N, Fields T, Howell DN,
Smith SR: Beneficial effect of plasmapheresis and intravenous
immunoglobulin on renal allograft survival of patients with acute
humoral rejection. Transplantation 2003; 75: 1490-1495
29. White NB, Greenstein SM, Cantafio AW, Schechner R, Glicklich
D, McDonough P, Pullman J, Mohandas K, Boctor F, Uehlinger
J, Tellis V: Successful rescue therapy with plasmapheresis and
intravenous immunoglobulin for acute humoral renal transplant
rejection. Transplantation 2004; 78: 772-774
30. Lehrich RW, Rocha PN, Reinsmoen N, Greenberg A, Butterly
DW, Howell DN, Smith SR: Intravenous immunoglobulin and
plasmapheresis in acute humoral rejection: Experience in renal
allograft transplantation. Hum Immunol 2005; 66: 350-358
31. Lefaucheur C, Nochy D, Andrade J, Verine J, Gautreau C, Charron
D, Hill GS, Glotz D, Suberbielle-Boissel C: Comparison of
combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg
in the treatment of antibody-mediated rejection. Am J Transplant
2009; 9: 1099-1107
32. Liu M, Ji SM, Tang Zh, Ji DX, Chen HP, Liu ZH, Li LS: C4dpositive
acute humoral renal allograft rejection: Rescue therapy
by immunoadsorption in combination with tacrolimus and mycophenolate mofetil. Transplant Proc 2004; 36: 2101-2103
33. Ulinski T: Recurrence of focal segmental glomerulosclerosis after
kidney transplantation: Strategies and outcome. Curr Opin Organ
Transplant 2010; 15: 628-632
34. Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A: Combination
treatment with plasmapheresis and rituximab for recurrent focal
segmental glomerulosclerosis after renal transplantation. Artif
Organs 2011; 35: 420-425
35. Davenport RD: Apheresis treatment of recurrent focal segmental
glomerulosclerosis after kidney transplantation: Re-analysis of
published case-reports and case-series. J Clin Apher 2001; 16:
175-178
36. Ponticelli C, Banfi G: Thrombotic microangiopathy after kidney
transplantation. Transpl Int 2006; 19: 789-794
37. Chiurchiu C, Ruggenenti P, Remuzzi G: Thrombotic
microangiopathy in renal transplantation. Ann Transplant 2002; 7:
28-33
38. Goplani KR, Vanikar AV, Shah PR, Gumber M, Feroz A, Patel HV,
Kasat P, Falodia J, Saboo D, Kaswaan K, Geerish MS, Pandya T,
Trivedi HL: Postrenal transplant hemolytic uremic syndrome/
thrombotic microangiopathy: Ahmedabad experience. Transplant
Proc 2008; 40: 1114-1116
Thank you for copying data from http://www.arastirmax.com
